Cure Genetics Competitors and Similar CompaniesClear all

Cure Genetics's competitors and similar companies include Zyngenia and Exicure.

	Cure Genetics Cure Genetics (also known as Suzhou Kerui Gene Biotechnology, 克睿基因) is a biotechnology company committed to developing applications of technologies in medicines and molecular diagnostics, which contribute to the treatment of cancers and genetic diseases.	Zyngenia Zyngenia is a company developing biotherapeutics that simultaneously target multiple physiologic pathways.	Exicure Exicure is a biotechnology company developing immunomodulatory and gene regulating drugs against validated targets.
Founding Date	Founding Date 2016	Founding Date 2009	Founding Date 2011
Type	Type Private	Type Private	Type Public
Tags	Tags Healthcare biotech drug development genetics oncology pharma	Tags Healthcare biotech drug development genetics oncology pharma	Tags Healthcare biotech drug development genetics oncology pharma
Locations	Locations HQ	Locations Washington, US HQ	Locations Skokie, US HQ Chicago, US
Employees	Employees 15	Employees N/A	Employees 29
Funding
Latest funding round	Latest funding round $ 9.5m (over 6 years ago)	Latest funding round $ 25m (almost 16 years ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 26.5m	Total funding raised $ 25m	Total funding raised $ 94m

For sources of this data, please see the company profile

Washington, US

Zyngenia is a company developing biotherapeutics that simultaneously target multiple physiologic pathways.

Skokie, US

Employees

Exicure is a biotechnology company developing immunomodulatory and gene regulating drugs against validated targets.

Funding